179
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Biomedical Applications of Silver Nitroprusside Nanoparticles

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1627-1630 | Received 15 Mar 2021, Accepted 20 Apr 2021, Published online: 01 Jul 2021

References

  • Hu C , ZhangY, SongM, DengY, SunX, LeiY. Prolonged use of nitric oxide donor sodium nitroprusside induces ocular hypertension in mice. Exp. Eye Res.202, 108280 (2021).
  • Vesey CJ , ColePV. Blood cyanide and thiocyanate concentrations produced by long-term therapy with sodium nitroprusside. Br. J. Anaesth.57(2), 148–155 (1985).
  • Cobb A , ThorntonL. Sodium nitroprusside as a hyperinflation drug and therapeutic alternatives. J. Pharm. Pract.31(4), 374–381 (2018).
  • Hottinger DG , BeebeDS, KozhimannilT, PrielippRC, BelaniKG. Sodium nitroprusside in 2014: a clinical concepts review. J. Anaesthesiol. Clin. Pharmacol.30(4), 462–471 (2014).
  • Friederich JA , ButterworthJF. Sodium nitroprusside: twenty years and counting. Anesth. Analg.81(1), 152–162 (1995).
  • Holme MR , SharmanT. Sodium nitroprusside. In: StatPearls.StatPearls Publishing, FL, USA (2020). https://pubmed.ncbi.nlm.nih.gov/32491419/
  • Varon J . Treatment of acute severe hypertension: current and newer agents. Drugs68(3), 283–297 (2008).
  • Chen G , RoyI, YangC, PrasadPN. Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy. Chem. Rev.116(5), 2826–2885 (2016).
  • Barui AK , NethiSK, HaqueS, BasuthakurP, PatraCR. Recent development of metal nanoparticles for angiogenesis study and their therapeutic applications. ACS Appl. Bio. Mater.2(12), 5492–5511 (2019).
  • Solak K , MaviA, YılmazB. Disulfiram-loaded functionalized magnetic nanoparticles combined with copper and sodium nitroprusside in breast cancer cells. Mater. Sci. Eng. C Mater. Biol. Appl.119, 111452 (2021).
  • Rao BR , KotcherlakotaR, NethiSKet al. Ag2[Fe(CN)5NO] nanoparticles exhibit antibacterial activity and wound healing properties. ACS Bio. Sci. Eng.4(9), 3434–3449 (2018).
  • Feng T , WanJ, LiPet al. A novel NIR-controlled NO release of sodium nitroprusside-doped Prussian blue nanoparticle for synergistic tumor treatment. Biomaterials214, 119213 (2019).
  • Silva Filho PM , PazIA, NascimentoNRFet al. Incorporation of nitroprusside on silica nanoparticles-a strategy for safer use of this NO donor in therapy. Mol. Pharm.16(7), 2912–2921 (2019).
  • Faraji J , SepehriA, Salcedo-ReyesJC. Titanium dioxide nanoparticles and sodium nitroprusside alleviate the adverse effects of cadmium stress on germination and seedling growth of wheat (Triticum aestivum L.). Univ. Sci.23(1), 61–87 (2018).
  • Rao BR , KumarR, HaqueSet al. Ag2[Fe(CN)5NO]-fabricated hydrophobic cotton as a potential wound healing dressing: an in vivo approach. ACS Appl. Mater. Interfaces13(9), 10689–10704 (2021).
  • Abduldayem HA . Silver nitroprusside. Int. J. Mag. Eng. Technol. Manag. Res.5(3), 86–92 (2018).
  • Stensberg MC , WeiQ, McLamoreES, PorterfieldDM, WeiA, SepúlvedaMS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond.)6(5), 879–898 (2011).
  • Ferdous Z , NemmarA. Health impact of silver nanoparticles: a review of the biodistribution and toxicity following various routes of exposure. Int. J. Mol. Sci.21(7), 2375 (2020).
  • Liu F , MahmoodM, XuYet al. Effects of silver nanoparticles on human and rat embryonic neural stem cells. Front. Neurosci.9, 115 (2015).
  • Boudreau MD , ImamMS, ParedesAMet al. Differential effects of silver nanoparticles and silver ions on tissue accumulation, distribution, and toxicity in the Sprague Dawley rat following daily oral gavage administration for 13 weeks. Toxicol. Sci.150(1), 131–160 (2016).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.